Oric Pharmaceuticals (ORIC) Interest Coverage Ratio (2019 - 2026)
Oric Pharmaceuticals' (ORIC) quarterly Interest Coverage Ratio came in at 0.4 in Q1 2026, up 85.73% YoY from 0.21 in Q1 2025, and up 12.9% on a QoQ basis from 0.46 in Q3 2025.
Oric Pharmaceuticals (ORIC) Interest Coverage Ratio (2019 - 2026) Analysis & Trends
Oric Pharmaceuticals (ORIC) has 8 years of Interest Coverage Ratio data on file, last reported at 0.4 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 85.73% year-over-year to 0.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.51 (up 87.95% YoY) and the FY2025 annual result came in at 0.67, up 18.77% from the prior year.
- Interest Coverage Ratio climbed to 0.4 in Q1 2026, from 0.46 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.22 in Q4 2022 to a low of 11.23 in Q3 2022.
- A 5-year average of 2.03 and a median of 0.79 in 2023 frame the typical range for Interest Coverage Ratio.
- The widest YoY moves for Interest Coverage Ratio: up 99.62% in 2022, down 2805.79% in 2022.
- Tracing ORIC's Interest Coverage Ratio over 5 years: stood at 0.22 in 2022, then declined by 8.4% to 0.24 in 2023, then rose by 2.98% to 0.23 in 2024, then slumped by 99.16% to 0.46 in 2025, then rose by 12.9% to 0.4 in 2026.
- The last three Interest Coverage Ratio figures came in at 0.4 (Q1 2026), 0.46 (Q3 2025), and 0.69 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Oric Pharmaceuticals | 1.44 Bn | 1.44 Bn | - | -0.65 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.65 |
| Mar 31, 2026 | -0.40 |
| Sep 30, 2025 | -0.46 |
| Jun 30, 2025 | -0.69 |
| Mar 31, 2025 | -2.79 |
| Dec 31, 2024 | -0.23 |
| Sep 30, 2024 | -0.74 |
| Jun 30, 2024 | -1.56 |
| Mar 31, 2024 | -0.32 |
| Dec 31, 2023 | -0.24 |
| Sep 30, 2023 | -1.88 |
| Jun 30, 2023 | -0.85 |
| Mar 31, 2023 | -1.99 |
| Dec 31, 2022 | -0.22 |
| Sep 30, 2022 | -11.23 |
| Jun 30, 2022 | -4.65 |
| Mar 31, 2022 | -4.24 |
| Dec 31, 2021 | -57.01 |
| Sep 30, 2021 | -0.39 |
| Jun 30, 2021 | -0.58 |